Actress, author and activist Gabrielle Union
will share her menopause story in live-streamed event on November 9
as part of her partnership with Clearblue® and its New Menopause
Stage Indicator
Clearblue®, the world’s #1 selling brand in home pregnancy and
fertility tests1, has teamed up with actress Gabrielle Union, an
active advocate for women’s health, to turn up the volume on the
menopause conversation. On the heels of the launch of the brand’s
newest innovation, the Menopause Stage Indicator, as part of the
partnership, Union will share more about her own personal menopause
story in a live-streamed event taking place on November 9th at
12:30pm EST alongside Dr. Heather Hisrch, MD, MS, MSCP and Dr.
Fiona Clancy, PhD, R&D senior director at Clearblue.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20231109375918/en/
Gabrielle Union teams up with Clearblue
to continue turning up the volume on menopause conversations.
(Photo: Business Wire)
“I’m so proud to partner with Clearblue® and join their mission
to help women feel educated and empowered as they take on
perimenopause and menopause,” said Union. “Menopause is a subject
we still often ignore, and it leaves women feeling confused,
silenced and completely unprepared. I started my perimenopause
journey ‘early’ and struggled to navigate the intense physical and
emotional symptoms that usurped my entire being. Having a product
like the Menopause Stage Indicator at my disposal would have been
an eye-opening resource for me as I began searching for
answers.”
The Clearblue® Menopause Stage Indicator is the first and only
product to combine both a woman’s urine FSH results with her age
and cycle history to indicate her likely menopause stage,2 with
results securely stored on the free-to-download app,3 Menopause
Stage – Clearblue® me. A woman can use the app to download her
personalized report to use in conversation with her doctor to
understand more about what she is experiencing.
Nearly half of all women confuse their menopause symptoms with
other health conditions such as stress or the flu and may not
realize it’s actually the start of the menopause journey.4 By
partnering with Union, Clearblue® hopes to break the silence
surrounding menopause and help equip women with the information
they need to embrace this chapter in their lives.
“It is an honor to partner with Gabrielle and collectively work
toward the same goal of empowering women on their menopause
journey,” said Leah Wood, Clearblue® Brand Director. “As someone
who has been open about her own journey, we believe Gabrielle can
help many women who, like her, may have confused early symptoms
with something else.”
“Women don’t know enough about the menopausal transition,” said
Claire Gill, founder and president of the National Menopause
Foundation. “In our recent survey, over a third of respondents said
they knew very little to almost nothing about menopause before
experiencing symptoms and felt unprepared5. In order to best
support women, we need to ensure there are accessible resources
available, like the Clearblue® Menopause Stage Indicator that can
give women a launch pad to be more in control of their
journeys.”
The Clearblue® Menopause Stage Indicator is available for
purchase at retailers across the United States. More information
can be found at https://clearblue.com/menopause/stage-indicator, or
by following along on social with the hashtag #MenoStage or
@clearblue on Instagram. To tune in to the livestream panel event
with Gabrielle click HERE.
About Clearblue®
Clearblue® is the World’s No.1 selling brand in home
pregnancy and fertility tests1. Consumers trust the Clearblue®
brand for its reputation of delivering clear and accurate results.
The Clearblue® product range is built on a strong foundation
of peer-reviewed science and consumer understanding.
Clearblue® is supported by over 35 years of expertise,
quality, and innovation in consumer diagnostics. Clearblue®
pregnancy, fertility and ovulation products are developed with
leading healthcare experts and Clearblue® is the #1 OB-GYN
Recommended ovulation brand. The Clearblue® family of
products includes the Clearblue® Fertility Monitor,
Clearblue® Advanced Digital Ovulation Test,
Clearblue® Digital Ovulation Test, Clearblue® Easy
Ovulation Test, Clearblue® Digital Pregnancy Test,
Clearblue® Rapid Detection Pregnancy Test, Clearblue®
Flip & Click Pregnancy Test, Clearblue® Early Detection
Pregnancy Test, Clearblue® Early Digital Pregnancy Test,
Clearblue® Advanced Trying For a Baby Kit and the
Clearblue® Trying for a Baby Kit. For more information visit
www.clearblue.com.
ABOUT PROCTER & GAMBLE
P&G serves consumers around the world with one of the
strongest portfolios of trusted, quality, leadership brands,
including Always®, Ambi Pur®, Ariel®, Bounty®, Charmin®, Crest®,
Dawn®, Downy®, Fairy®, Febreze®, Gain®, Gillette®, Head &
Shoulders®, Lenor®, Olay®, Oral-B®, Pampers®, Pantene®, SK-II®,
Tide®, Vicks®, and Whisper®. The P&G community includes
operations in approximately 70 countries worldwide. Please visit
https://www.pg.com for the latest news and information about
P&G and its brands. For other P&G news, visit us at
https://www.pg.com/news.
1#1 selling brand in home pregnancy and fertility tests. Based
on international sales compiled using independent market research
data. 2Only a healthcare professional can confirm your menopause
stage 3Compatible with most iPhones® and Android™ Phones. To find
out if your phone is compatible and if the app is available in the
country you live in, check out: www.clearblue.com/connectivity
4Menopause Habits & Practices Study. Catalyx, 2023. 1,004 US
women 40-55y.o. 5 MSL conducted an online survey, via Suzy.com,
about women and menopause with n=633 women, aged 25-65 years old,
between December 10-11, 2022. Of the respondent survey base, there
were n=157 (25-39 year old women) and n=313 (40-55 year old women)
and n=163 (56-65 year old women.)
This product is not suitable if you are pregnant, breastfeeding,
are taking hormonal birth control, hormone replacement therapy,
medications affecting FSH, have PCOS, or after surgical procedures
which affect your cycle. If unsure about suitability, speak to your
healthcare professional.
Not for contraceptive use.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231109375918/en/
Velvet Gogol Bennett P&G Personal Health Care North America
& Global Communications 513-634-5576 gogolbennett.vc@pg.com
Alan Danzis Alan.Danzis@mslgroup.com
Procter and Gamble (NYSE:PG)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
Procter and Gamble (NYSE:PG)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024